Andrea Sherk, Ph.D. - Publications

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Cell Biology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Shatnawi A, Norris JD, Chaveroux C, Jasper JS, Sherk AB, McDonnell DP, Giguère V. ELF3 is a repressor of androgen receptor action in prostate cancer cells. Oncogene. 33: 862-71. PMID 23435425 DOI: 10.1038/Onc.2013.15  0.554
2009 Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Molecular Endocrinology (Baltimore, Md.). 23: 1385-96. PMID 19460858 DOI: 10.1210/Me.2009-0010  0.521
2009 Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, Cui H, Anderson E, Fan D, Dye DA, Deng X, Kazmin D, Chang CY, Willson TM, McDonnell DP. Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chemistry & Biology. 16: 452-60. PMID 19389631 DOI: 10.1016/J.Chembiol.2009.01.016  0.543
2008 Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Trizna W, Hammond M, Patterson JR, Thompson SK, Kazmin D, Norris JD, McDonnell DP. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Research. 68: 7475-83. PMID 18794135 DOI: 10.1158/0008-5472.Can-08-1047  0.519
2007 Wittmann BM, Sherk A, McDonnell DP. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. Cancer Research. 67: 9549-60. PMID 17909066 DOI: 10.1158/0008-5472.Can-07-1590  0.581
2007 Sherk AB, McDonnell DP. Molecular pharmacology of estrogen and progesterone receptors Menopause. 17-28. DOI: 10.1016/B978-012369443-0/50004-1  0.548
2007 Sherk AB, McDonnell DP. Molecular pharmacology of estrogen and progesterone receptors Menopause. 17-28. DOI: 10.1016/B978-012369443-0/50004-1  0.548
2002 Norris JD, Fan D, Sherk A, McDonnell DP. A negative coregulator for the human ER. Molecular Endocrinology (Baltimore, Md.). 16: 459-68. PMID 11875103 DOI: 10.1210/Mend.16.3.0787  0.518
Show low-probability matches.